Cargando…
Could a defective epithelial sodium channel lead to bronchiectasis
BACKGROUND: Bronchiectasis is defined as a permanent dilation of the airways arising from chronic bronchial inflammation/infection. In 50% of cases, no etiology can be identified. Recently, the role of the epithelial sodium channel ENaC has been pointed out in the pathophysiology of cystic fibrosis,...
Autores principales: | Fajac, Isabelle, Viel, Marion, Sublemontier, Sébastien, Hubert, Dominique, Bienvenu, Thierry |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435537/ https://www.ncbi.nlm.nih.gov/pubmed/18507830 http://dx.doi.org/10.1186/1465-9921-9-46 |
Ejemplares similares
-
An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CF(TM) 1
por: Goss, Christopher H., et al.
Publicado: (2020) -
Poor Survival in Rheumatoid Arthritis Associated with Bronchiectasis: A Family-Based Cohort Study
por: Puéchal, Xavier, et al.
Publicado: (2014) -
Bronchiectasis—Could Immunonutrition Have a Role to Play in Future Management?
por: Derbyshire, Emma J., et al.
Publicado: (2021) -
Structure of the human epithelial sodium channel by cryo-electron microscopy
por: Noreng, Sigrid, et al.
Publicado: (2018) -
Molecular principles of assembly, activation, and inhibition in epithelial sodium channel
por: Noreng, Sigrid, et al.
Publicado: (2020)